These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 21367958)
1. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Pomerantz MM; Werner L; Xie W; Regan MM; Lee GS; Sun T; Evan C; Petrozziello G; Nakabayashi M; Oh WK; Kantoff PW; Freedman ML Cancer Prev Res (Phila); 2011 May; 4(5):719-28. PubMed ID: 21367958 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Penney KL; Salinas CA; Pomerantz M; Schumacher FR; Beckwith CA; Lee GS; Oh WK; Sartor O; Ostrander EA; Kurth T; Ma J; Mucci L; Stanford JL; Kantoff PW; Hunter DJ; Stampfer MJ; Freedman ML Clin Cancer Res; 2009 May; 15(9):3223-30. PubMed ID: 19366828 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899 [TBL] [Abstract][Full Text] [Related]
4. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients. He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378 [TBL] [Abstract][Full Text] [Related]
5. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Helfand BT; Roehl KA; Cooper PR; McGuire BB; Fitzgerald LM; Cancel-Tassin G; Cornu JN; Bauer S; Van Blarigan EL; Chen X; Duggan D; Ostrander EA; Gwo-Shu M; Zhang ZF; Chang SC; Jeong S; Fontham ET; Smith G; Mohler JL; Berndt SI; McDonnell SK; Kittles R; Rybicki BA; Freedman M; Kantoff PW; Pomerantz M; Breyer JP; Smith JR; Rebbeck TR; Mercola D; Isaacs WB; Wiklund F; Cussenot O; Thibodeau SN; Schaid DJ; Cannon-Albright L; Cooney KA; Chanock SJ; Stanford JL; Chan JM; Witte J; Xu J; Bensen JT; Taylor JA; Catalona WJ Hum Genet; 2015 Apr; 134(4):439-50. PubMed ID: 25715684 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy. Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942 [TBL] [Abstract][Full Text] [Related]
7. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657 [TBL] [Abstract][Full Text] [Related]
8. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population. Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531 [TBL] [Abstract][Full Text] [Related]
9. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population. Beikzadeh B; Angaji SA; Abolhasani M BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536 [TBL] [Abstract][Full Text] [Related]
10. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies. Kim S; Shin C; Jee SH Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA; Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936 [TBL] [Abstract][Full Text] [Related]
12. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Xu J; Isaacs SD; Sun J; Li G; Wiley KE; Zhu Y; Hsu FC; Wiklund F; Turner AR; Adams TS; Liu W; Trock BJ; Partin AW; Chang B; Walsh PC; Grönberg H; Isaacs W; Zheng S Clin Cancer Res; 2008 Sep; 14(18):5819-24. PubMed ID: 18794092 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116 [TBL] [Abstract][Full Text] [Related]
14. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness. Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597 [TBL] [Abstract][Full Text] [Related]
15. Replication of prostate cancer risk loci in a Japanese case-control association study. Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility loci associated with prostate cancer progression and mortality. Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480 [TBL] [Abstract][Full Text] [Related]
17. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival. Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. Knipe DW; Evans DM; Kemp JP; Eeles R; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Donovan JL; Hamdy FC; Neal DE; Smith GD; Lathrop M; Martin RM Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1356-1365. PubMed ID: 24753544 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer risk alleles are associated with prostate cancer volume and prostate size. Reinhardt D; Helfand BT; Cooper PR; Roehl KA; Catalona WJ; Loeb S J Urol; 2014 Jun; 191(6):1733-6. PubMed ID: 24345439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]